Synthesis and structure-activity relationship study of new biaryl amide derivatives and their inhibitory effects against hepatitis C virus
- 1 December 2021
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 228, 114033
Abstract
No abstract availableKeywords
Funding Information
- Chinese Academy of Meteorological Sciences (2017-I2M-3-012)
This publication has 34 references indexed in Scilit:
- SCYX-7158, an Orally-Active Benzoxaborole for the Treatment of Stage 2 Human African TrypanosomiasisPLOS Neglected Tropical Diseases, 2011
- Host apolipoprotein b messenger RNA-editing enzyme catalytic polypeptide-like 3G is an innate defensive factor and drug target against hepatitis C virusHepatology, 2011
- Structural Mechanism of the Pan‐BCR‐ABL Inhibitor Ponatinib (AP24534): Lessons for Overcoming Kinase Inhibitor ResistanceChemical Biology & Drug Design, 2010
- Small Molecule Modifiers of MicroRNA miR-122 Function for the Treatment of Hepatitis C Virus Infection and Hepatocellular CarcinomaJournal of the American Chemical Society, 2010
- Small Molecular Compounds Inhibit HIV-1 Replication through Specifically Stabilizing APOBEC3GJournal of Biological Chemistry, 2010
- Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C InfectionNew England Journal of Medicine, 2009
- APOBEC3G Incorporation into Human Immunodeficiency Virus Type 1 ParticlesJournal of Virology, 2004
- Human Apolipoprotein B mRNA-editing Enzyme-catalytic Polypeptide-like 3G (APOBEC3G) Is Incorporated into HIV-1 Virions through Interactions with Viral and Nonviral RNAsJournal of Biological Chemistry, 2004
- Inhibition of Hepatitis B Virus Replication by APOBEC3GScience, 2004
- The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNANature, 2003